Purpose
to develop a list of consensus HIV-1 antiretroviral (ARV) drug-resistance mutations (DRMs) for the sensitive and specific diagnosis of HIV-1 drug resistance in resource-limited settings and to create “Consensus Mutations” and “Assay Validation” guidance documents to assist technology companies developing POC multiplexed assays for HIV-1 drug resistance
Grantee
Division
Global Health
Date
OCTOBER 2013
Region served
GLOBAL
Committed amount
$148,456
Grant topic
HIV
Duration (months)
12
Grantee location
Redwood City, California, United States
Related work
More about our work
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.